PLASMACYTOMA

Clinical trials for PLASMACYTOMA explained in plain language.

Never miss a new study

Get alerted when new PLASMACYTOMA trials appear

Sign up with your email to follow new studies for PLASMACYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Terminated 1

Promising new combo therapy for rare plasma cell tumors shows early potential

Disease control Ongoing

This study tests whether combining two drugs (lenalidomide and CC-486) with radiation therapy is safe and effective for people with plasmacytoma, a type of plasma cell tumor that can be linked to multiple myeloma. About 21 participants will receive the treatment to see if it lead…

Matched conditions: PLASMACYTOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

PLASMACYTOMA

Get alerted when new PLASMACYTOMA trials appear

Promising new combo therapy for rare plasma cell tumors shows early potential